ArticleClinical pharmacology and therapeutics2026
Causal Inference Approaches to Estimating the Effect of Ibrutinib Dose Modifications on Progression-Free Survival in Chronic Lymphocytic Leukemia.
Viet Dang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.